UBS downgraded Confluent (CFLT) to Neutral from Buy with a price target of $31, up from $29, after the company agreed to be acquired by IBM (IBM) for $31 per share or $11B. The firm’s base case is that the deal will close.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
- Confluent’s Acquisition by IBM: Hold Rating Amid Valuation and Product Challenges
- Confluent downgraded to Perform from Outperform at Oppenheimer
- Confluent downgraded to Sector Perform from Outperform at RBC Capital
- Confluent downgraded to Peer Perform from Outperform at Wolfe Research
- Confluent downgraded to Neutral from Buy at DA Davidson